APA (7th ed.) Citation

Wen Kou, Yan Yan Lin, Fei Su, Yue Xiang, Hui Qiao, Xin'An Wu, & Xiao-Ming Hou. (2022). The influence of pharmaceutical care in patients with advanced non-small-cell lung cancer receiving combination cytotoxic chemotherapy and PD-1/PD-L1 inhibitors. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Wen Kou, Yan Yan Lin, Fei Su, Yue Xiang, Hui Qiao, Xin'An Wu, and Xiao-Ming Hou. The Influence of Pharmaceutical Care in Patients with Advanced Non-small-cell Lung Cancer Receiving Combination Cytotoxic Chemotherapy and PD-1/PD-L1 Inhibitors. Frontiers Media S.A., 2022.

MLA (9th ed.) Citation

Wen Kou, et al. The Influence of Pharmaceutical Care in Patients with Advanced Non-small-cell Lung Cancer Receiving Combination Cytotoxic Chemotherapy and PD-1/PD-L1 Inhibitors. Frontiers Media S.A., 2022.